These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 26440671)
21. Novel Pathogenic Variant (c.580C>T) in the CPS1 Gene in a Newborn With Carbamoyl Phosphate Synthetase 1 Deficiency Identified by Whole Exome Sequencing. Choi R; Park HD; Yang M; Ki CS; Lee SY; Kim JW; Song J; Chang YS; Park WS Ann Lab Med; 2017 Jan; 37(1):58-62. PubMed ID: 27834067 [TBL] [Abstract][Full Text] [Related]
22. Split AAV-Mediated Gene Therapy Restores Ureagenesis in a Murine Model of Carbamoyl Phosphate Synthetase 1 Deficiency. Nitzahn M; Allegri G; Khoja S; Truong B; Makris G; Häberle J; Lipshutz GS Mol Ther; 2020 Jul; 28(7):1717-1730. PubMed ID: 32359471 [TBL] [Abstract][Full Text] [Related]
24. Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder. Diez-Fernandez C; Häberle J Expert Opin Ther Targets; 2017 Apr; 21(4):391-399. PubMed ID: 28281899 [TBL] [Abstract][Full Text] [Related]
25. Novel mutations (H337R and 238-362del) in the CPS1 gene cause carbamoyl phosphate synthetase I deficiency. Aoshima T; Kajita M; Sekido Y; Kikuchi S; Yasuda I; Saheki T; Watanabe K; Shimokata K; Niwa T Hum Hered; 2001; 52(2):99-101. PubMed ID: 11474210 [No Abstract] [Full Text] [Related]
26. 4217C>A polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy. Inoue K; Suzuki E; Takahashi T; Yamamoto Y; Yazawa R; Takahashi Y; Imai K; Miyakawa K; Inoue Y; Tsuji D; Hayashi H; Itoh K Epilepsy Res; 2014 Aug; 108(6):1046-51. PubMed ID: 24888247 [TBL] [Abstract][Full Text] [Related]
27. Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Laemmle A; Hahn D; Hu L; Rüfenacht V; Gautschi M; Leibundgut K; Nuoffer JM; Häberle J Mol Genet Metab; 2015 Mar; 114(3):438-44. PubMed ID: 25639153 [TBL] [Abstract][Full Text] [Related]
28. Hepatic glutamine synthetase augmentation enhances ammonia detoxification. Soria LR; Nitzahn M; De Angelis A; Khoja S; Attanasio S; Annunziata P; Palmer DJ; Ng P; Lipshutz GS; Brunetti-Pierri N J Inherit Metab Dis; 2019 Nov; 42(6):1128-1135. PubMed ID: 30724386 [TBL] [Abstract][Full Text] [Related]
29. A 36-year-old Man with Repeated Short-term Transient Hyperammonemia and Impaired Consciousness with a Confirmed Carbamoyl Phosphate Synthase 1 Gene Monoallelic Mutation. Ishikawa R; Sugimoto T; Abe T; Ohno N; Tazuma T; Giga M; Naito H; Kono T; Nomura E; Hara K; Yorifuji T; Yamawaki T Intern Med; 2022 May; 61(9):1387-1392. PubMed ID: 34670888 [TBL] [Abstract][Full Text] [Related]
30. Structural organization of the human carbamyl phosphate synthetase I gene (CPS1) and identification of two novel genetic lesions. Funghini S; Donati MA; Pasquini E; Zammarchi E; Morrone A Hum Mutat; 2003 Oct; 22(4):340-1. PubMed ID: 12955727 [TBL] [Abstract][Full Text] [Related]
31. Structure of human carbamoyl phosphate synthetase: deciphering the on/off switch of human ureagenesis. de Cima S; Polo LM; Díez-Fernández C; Martínez AI; Cervera J; Fita I; Rubio V Sci Rep; 2015 Nov; 5():16950. PubMed ID: 26592762 [TBL] [Abstract][Full Text] [Related]
32. The Application of Next-Generation Sequencing (NGS) in Neonatal-Onset Urea Cycle Disorders (UCDs): Clinical Course, Metabolomic Profiling, and Genetic Findings in Nine Chinese Hyperammonemia Patients. Zhou Q; Huang H; Ma L; Zhu T Biomed Res Int; 2020; 2020():5690915. PubMed ID: 32934962 [TBL] [Abstract][Full Text] [Related]
33. Neonatal-onset carbamoyl phosphate synthetase I deficiency: A case report. Yang X; Shi J; Lei H; Xia B; Mu D Medicine (Baltimore); 2017 Jun; 96(26):e7365. PubMed ID: 28658158 [TBL] [Abstract][Full Text] [Related]
34. Novel human pathological mutations. Gene symbol: CPS1. Disease: carbamoyl phosphate synthetase I deficiency. Khayat M Hum Genet; 2009 Apr; 125(3):336. PubMed ID: 19309799 [No Abstract] [Full Text] [Related]
37. A case of carbamoyl phosphate synthetase 1 deficiency presenting symptoms at one month of age. Ono H; Suto T; Kinoshita Y; Sakano T; Furue T; Ohta T Brain Dev; 2009 Nov; 31(10):779-81. PubMed ID: 19167850 [TBL] [Abstract][Full Text] [Related]
38. CPS1: Looking at an ancient enzyme in a modern light. Nitzahn M; Lipshutz GS Mol Genet Metab; 2020 Nov; 131(3):289-298. PubMed ID: 33317798 [TBL] [Abstract][Full Text] [Related]
39. Gene structure of human carbamylphosphate synthetase 1 and novel mutations in patients with neonatal onset. Häberle J; Schmidt E; Pauli S; Rapp B; Christensen E; Wermuth B; Koch HG Hum Mutat; 2003 Apr; 21(4):444. PubMed ID: 12655559 [TBL] [Abstract][Full Text] [Related]
40. Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes. Shi D; Zhao G; Ah Mew N; Tuchman M Mol Genet Metab; 2017 Mar; 120(3):198-206. PubMed ID: 28007335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]